rare genetic disease with myoclonus as a major feature
ORPHA: 3070672 Treatments Available
Overview
human disease
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Valproic Acid | Oral tablets 250mg, 500mg; Oral solution 250mg/5mL; IV infusion 100mg/mL | FDA Approved | 12 | 7d |
| Levetiracetam | Oral tablet 250mg, 500mg, 750mg, 1000mg; Oral solution 100mg/mL; IV infusion 500mg/5mL | FDA Approved, EMA Approved | 11 | 3d |
Classification & Codes
Orphanet Code
ORPHA:307067rare genetic disease with myoclonus as a major feature
| Orphanet | ORPHA:307067 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO